Live Interview with Dr. Denise Faustman, Director of Immunobiology Massachusetts General Hospital

Event Details

Live Interview with Dr. Denise Faustman, Director of Immunobiology Massachusetts General Hospital

Time: July 24, 2014 from 11am to 12pm
Location: TuDiabetes homepage
Website or Map: http://www.TuDiabetes.org
Event Type: live interview, videochat
Organized By: Emily Coles
Latest Activity: Jul 24

Export to Outlook or iCal (.ics)

Event Description

11am PT, 2pm ET, 7pm GMT

What time is this where you are?

How to watch this live event

Denise L. Faustman, MD, PhD, Director of Immunobiology, Massachusetts General Hospital & Associate Professor of Medicine, Harvard Medical School

Denise Faustman, MD, PhD, is Director of the Immunobiology Laboratory at the Massachusetts General Hospital (MGH) and an Associate Professor of Medicine at Harvard Medical School. She is currently leading a human clinical trial program to test the efficacy of the BCG vaccine as a treatment to reverse long-term type 1 diabetes. They are currently preparing to enroll patients in a Phase II study. Dr. Faustman’s research has been highlighted in publications including The Wall Street JournalThe New York Times, Los Angeles Times, and Scientific American. She earned her MD and PhD from Washington University School of Medicine in St. Louis, Missouri, and completed her internship, residency, and fellowships in internal medicine and endocrinology at the Massachusetts General Hospital.

Comment Wall

Comment

RSVP for Live Interview with Dr. Denise Faustman, Director of Immunobiology Massachusetts General Hospital to add comments!

Join Diabetes community by Diabetes Hands Foundation: TuDiabetes

Comment by etta amy on July 24, 2014 at 10:01am

About a year ago, I traveled to Boston to donate some blood. I am currently on week 3 of a six week, long distance study that essentially involves drinking Boost and mailing a urine sample back to Boston.

Comment by Brunetta on July 24, 2014 at 7:03am

My questions for Dr. Faustman are:
(1) Have the trials with BCG that produced a reversal of the "rogue" t-cells in the diabetic mice, ridding them of the need for exogenous insulin, which extended through a regular mouse lifetime, been replicated in a small trial with humans? I seem to have read something about that.
(2)Will the upcoming Phase II testing defelop an algorithm for BCG dosing in humans? If so, what factors will be used to determine this?
(3) I think I am too old to be Phase II participant, as I will be 60 in December. I read that 60 or maybe 61 is the cut-off age..yet, I am willing to participate in anyway as I can to help out others. Just my comment.

Thanks for coming on TuDiabetes, Dr. Faustman. We really appreciate your work.

Comment by Judith in Portland on July 23, 2014 at 8:46pm

Oooh Brunetta and Mee--- I love that you have participated and can give us some personal insight!....Blessings

Comment by meee on July 23, 2014 at 7:58pm

I'm looking forward to this too! I have also donated blood once at Dr. Faustman's lab but I was unfortunately to fatigued to go last time- hopefully I will donate again soon.

Comment by Judith in Portland on July 23, 2014 at 7:42pm

I have followed her work from afar for sometime. I look forward to having my lo-carb lunch with her tomorrow---Teehee. Well done, Emily. These interview events just keep getting better and better!. Polonsky, for instance, meant a lot to me, as did others...Blessings, as ever...

Comment by Brunetta on July 23, 2014 at 11:28am

I definitely want to check this out. I am a three- time blood donator to Dr. Faustman's study at Massachusetts General Hospital. I have m et her personally and would love to chat with her again. Fascinating and caring woman is she!!

Attending (16)

Might attend (4)

Not Attending (1)

Advertisement



REsources

From the Diabetes Hands Foundation blog...

#MedicareCoverCGM Panel Discussion

If you follow the diabetes online community, you know that #MedicareCoverCGM is a big deal. We have continued to raise awareness on #MedicareCoverCGM because we believe that ALL people living with diabetes should have access to continuous glucose monitors (CGM). With Read on! →

#WalkWithD: Making MORE Sense of Diabetes

  A few years ago, we at Diabetes Hands Foundation reached out to the members on TuDiabetes and asked them to share their perspective of life with diabetes through one of the five senses, as part of an initiative called Read on! →

Diabetes Hands Foundation Team

DHF TEAM

Manny Hernandez
(Co-Founder, Editor, has LADA)

Emily Coles
(Head of Communities, has type 1)

Mila Ferrer
(EsTuDiabetes Community Manager, mother of a child with type 1)

Mike Lawson
(Head of Experience, has type 1)

Corinna Cornejo
(Development Manager, has type 2)

Desiree Johnson  (Administrative and Programs Assistant, has type 1)


DHF VOLUNTEERS


Lead Administrator

Bradford (has type 1)


Administrators

Lorraine (mother of type 1)
Marie B (has type 1)

Brian (bsc) (has type 2)

Gary (has type 2)

David (dns) (type 2)

 

LIKE us on Facebook

Spread the word

Loading…

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

© 2014   A community of people touched by diabetes, run by the Diabetes Hands Foundation.

Badges  |  Contact Us  |  Terms of Service